Insurance

Turning Complexity into Clarity For self-funded employers, today’s healthcare landscape brings both opportunity and risk. Rising costs, specialty drugs, and unpredictable claims can quickly destabilize a plan, making stop loss coverage not just a safeguard, but a strategy. By serving as strategic partners, underwriters can design tailored stop loss solutions that protect against catastrophic losses…

Combating the Risks of Self-Funding As more employers seek greater control over healthcare costs and benefits, self-funded health plans continue to grow in popularity. While these plans offer flexibility and potential savings, they also introduce new layers of complexity, particularly around risk management. Understanding and mitigating risk is the key to a long-term, successful self-funded…

What is Self-Funding? Self-funded health insurance is a strategy that allows employers to directly fund their employees’ healthcare costs instead of purchasing a traditional health insurance plan from an insurer. Under a self-funded health plan, the employer assumes the financial risk of healthcare claims, paying for services as they arise, rather than paying fixed premiums…

In the dynamic world of self-funded health plans, choosing the right stop loss insurance partner is akin to selecting a trusted ally in a high-stakes journey. The right partner not only provides financial protection but also ensures peace of mind. Here are six key factors to consider when selecting a stop loss partner: Expertise and…

What Is Stop Loss Insurance? Navigating Self-Funded Health Plans with the Safety Net of Stop Loss Stop loss insurance, also known as excess loss insurance, is a type of coverage designed to protect businesses that self-fund their employee benefit plans. Self-funding, or self-insurance, means that instead of paying fixed premiums to an insurance carrier, the…

Self-funding has emerged as an attractive alternative to the traditional fully-insured group health plans where employers and their members pay fixed premiums for coverage. So, what exactly is self-funding, and why are an increasing number of businesses of all sizes opting for this approach? Let’s outline the concept and explore its key benefits. Self-funding, also…

Today, the U.S. Food and Drug Administration approved two milestone treatments, Casgevy and Lyfgenia, representing the first cell-based gene therapies for the treatment of sickle cell disease (SCD) in patients 12 years and older. Additionally, one of these therapies, Casgevy, is the first FDA-approved treatment to utilize a type of novel genome editing technology, signaling…

Cell and gene therapies are curative treatments for diseases such as immune deficiencies, Hemophilia, Leukemia, and more. However, they are also incredibly expensive and potentially catastrophic for self-funded health plans. With our Gene Therapy Protection, Excess Reinsurance can help reduce our clients’ financial risk related to the therapies and put employers in a position to…

The Affordable Care Act (ACA) generally requires group health plans and health insurance issuers that offer group health coverage to prepare and distribute to plan participants and beneficiaries a brief standard summary of the plan’s benefits and coverage. This summary is called the summary of benefits and coverage (SBC). In order to help employers fulfill…